GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Adolor Corporation (ADLR) [hlAlert]

Rating:
Buy ADLR
up 6.71 %

Adolor Corporation (ADLR) rated Buy

Posted on: Wednesday,  Dec 5, 2007  1:25 PM ET by Broadpoint Capital

Broadpoint Capital rated Buy Adolor Corporation (NASDAQ: ADLR) on 12/05/2007, when the stock price was $4.47. Since
then, Adolor Corporation has gained 6.71% as of 12/09/2011's recent price of $4.77.
If you would have followed this Broadpoint Capital's recommendation on ADLR, you would have gained 6.71% of your investment in 1465 days.

Adolor Corporation is a biopharmaceutical company. The Company has specialized in the discovery and development of prescription pain management products. It has a number of product candidates in various stages of development, ranging from preclinical studies to pivotal clinical trials. On May 20, 2008, the United States Food and Drug Administration (FDA) approved the Company?s first product, ENTEREG (alvimopan), for the management of postoperative ileus following bowel resection surgery (POI). ENTEREG is specifically indicated to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. The Company in collaboration with Glaxo Group Limited (Glaxo), launched ENTEREG in the United States in mid-2008.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2007 1:25 PM Buy
None
4.47
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  45.87 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy